Study S002589

Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06682351
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 200
Start: 2024-11
Primary completion: 2027-12
Lead sponsor: Stanford University
Conditions: Prediabetes / Type 2 Diabetes
Interventions: DRUG:Metformin; DRUG:GLP-1A; DIETARY_SUPPLEMENT:MED
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in HbA1c [At month 0, month 4, month 8, month 11, month 15, month 18]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.